fashion -WSS

fashion

author：Wikipedia 2025-09-27 23:12:19 - browse：9245

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Prosthetic arm enables patients to feel the objects they grip

WSS

Advances in CAR

How to fix cancer clinical trials' diversity problem

Weighted lottery helped low

Childbirth

A rare thyroid diagnosis led to unexpected, all

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

explore

fashion

Sign up for D.C. Diagnosis

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Illumina names Agilent executive as new CEO

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Report: NIH

Apple is now the first public company to be valued at $3 trillion

Report: NIH

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A rare thyroid diagnosis led to unexpected, all

Hepatitis C has a cure — but many Americans still lack access to it

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Wikipedia

Stem cell treatment guidelines are released by FDA

Antibiotic resistance nearly killed me, so I'm raising awareness of it

David Sabatini, ex

Heat waves linked to early deliveries, preterm births in new study

Insmed lung disease drug hits target in key Phase 3 trial

NIH nominee Bertagnolli will get October confirmation hearing

hotspot

entertainment

explore

entertainment